Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 12204

1.

Treatment patterns for older veterans with localized prostate cancer.

Hoffman RM, Shi Y, Freedland SJ, Keating NL, Walter LC.

Cancer Epidemiol. 2015 Jul 27. pii: S1877-7821(15)00142-3. doi: 10.1016/j.canep.2015.07.005. [Epub ahead of print]

PMID:
26228494
2.

Botulinum toxin (OnabotulinumtoxinA) in the male non-neurogenic overactive bladder: clinical and quality of life outcomes.

Habashy D, Losco G, Tse V, Collins R, Chan L.

BJU Int. 2015 Jul 14. doi: 10.1111/bju.13110. [Epub ahead of print]

PMID:
26176660
3.

Expression levels of heat shock protein 27 and cellular FLICE-like inhibitory protein in prostate cancer correlate with Gleason score sum and pathologic stage.

Lee SW, Cho JM, Cho HJ, Kang JY, Kim EK, Yoo TK.

Korean J Urol. 2015 Jul;56(7):505-14. doi: 10.4111/kju.2015.56.7.505. Epub 2015 Jul 7.

4.

Multiparametric magnetic resonance imaging for prostate cancer: A review and update for urologists.

Yoo S, Kim JK, Jeong IG.

Korean J Urol. 2015 Jul;56(7):487-97. doi: 10.4111/kju.2015.56.7.487. Epub 2015 Jun 30. Review.

5.

10-year Mortality After Radical Prostatectomy for Localized Prostate Cancer in the Prostate Specific Antigen Screening Era.

Mendhiratta N, Lee T, Prabhu V, Llukani E, Lepor H.

Urology. 2015 Jul 8. pii: S0090-4295(15)00635-4. doi: 10.1016/j.urology.2015.05.034. [Epub ahead of print]

PMID:
26163812
6.

Pathologic Outcomes in Men with Low-risk Prostate Cancer Who Are Potential Candidates for Contemporary, Active Surveillance Protocols.

Kang HW, Lee JY, Kwon JK, Jeh SU, Jung HD, Cho KS, Ham WS, Choi YD.

J Korean Med Sci. 2015 Jul;30(7):932-6. doi: 10.3346/jkms.2015.30.7.932. Epub 2015 Jun 10.

7.

[EVALUATION OF DIAGNOSTIC SIGNIFICANCE OF PELVIC MRI IN PROSTATE CANCER PATIENTS].

Rasner PI, Kotenko DV, Kolontarev KB, Brodeckij BM, Pushkar DY.

Urologiia. 2015 Jan-Feb;(1):44-8. Russian.

PMID:
26094386
8.

Reply to Letter to the Editor: "The role of radiotherapy after radical prostatectomy" by Aktan and Koq.

Özkanli SŞ.

Turk J Med Sci. 2015;45(2):461. No abstract available.

PMID:
26084143
9.

The role of radiotherapy after radical prostatectomy.

Aktan M, Koç M.

Turk J Med Sci. 2015;45(2):460-1. No abstract available.

PMID:
26084142
10.

Comparison of perioperative outcomes between running versus interrupted vesicourethral anastomosis in open radical prostatectomy: A single-surgeon experience.

Lim JH, Park CM, Kim HK, Park JY.

Korean J Urol. 2015 Jun;56(6):443-8. doi: 10.4111/kju.2015.56.6.443. Epub 2015 Jun 1.

11.

Prostatic and urothelial metastasis in the same lymph node: a case report.

Pacella E, Ricci F, Colecchia M, Boccardo F, Lopez-Beltran A, Spina B.

Anal Quant Cytopathol Histpathol. 2015 Apr;37(2):139-43.

PMID:
26065235
12.

Significance of microvessel density in prostate cancer core biopsy.

Dugonjić AS, Usaj SK, Eri Z, Latinović LT.

Vojnosanit Pregl. 2015 Apr;72(4):317-27.

PMID:
26040177
13.

[Anesthetic management of robot-assisted radical prostatectomy].

Kazakov AS, Kolontarev KB, Pushkar' DIu, Pasechnik IN.

Khirurgiia (Mosk). 2015;(2):56-62. Review. Russian.

PMID:
26031821
14.

[Complications and effectiveness of treatment of patients with locally advanced prostate cancer after combined radiotherapy and radical prostatectomy with postoperative radiotherapy].

Solodky VA, Pavlov AY, Panshin GA, Tsybulsky AD, Garmash SV, Isaev TK, Kravtsov IB.

Vopr Onkol. 2015;61(1):145-8. Russian.

PMID:
26016162
15.

[Radiotherapy for local recurrences of prostate cancer after radical prostatectomy].

Grishina YA, Khmelevsky EV.

Vopr Onkol. 2015;61(1):7-13. Review. Russian.

PMID:
26016138
16.

Population-based study of long-term functional outcomes after prostate cancer treatment.

Carlsson S, Drevin L, Loeb S, Widmark A, Lissbrant IF, Robinson D, Johansson E, Stattin P, Fransson P.

BJU Int. 2015 May 8. doi: 10.1111/bju.13179. [Epub ahead of print]

PMID:
25959859
17.

Expression of Peroxisome Proliferator Activated Receptor gamma in Prostatic Adenocarcinoma.

Park HK, Kim H, Kim HG, Cho YM, Jung WY, Han HS, Hwang TS, Kwon GY, Lim SD.

J Korean Med Sci. 2015 May;30(5):533-41. doi: 10.3346/jkms.2015.30.5.533. Epub 2015 Apr 15.

18.
19.

Prostate Cancer Volume Estimation by Combining Magnetic Resonance Imaging and Targeted Biopsy Proven Cancer Core Length: Correlation with Cancer Volume.

Matsugasumi T, Baco E, Palmer S, Aron M, Sato Y, Fukuda N, Süer E, Bernhard JC, Nakagawa H, Azhar RA, Gill IS, Ukimura O.

J Urol. 2015 Apr 23. pii: S0022-5347(15)03853-7. doi: 10.1016/j.juro.2015.04.075. [Epub ahead of print]

PMID:
25912496
20.

Loss of YAP protein in prostate cancer is associated with Gleason score increase.

Hu X, Jia Y, Yu J, Chen J, Fu Q.

Tumori. 2015 Mar-Apr;101(2):189-93. doi: 10.5301/tj.5000238. Epub 2015 Apr 17.

PMID:
25908048
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk